These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 11747339)
21. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854 [TBL] [Abstract][Full Text] [Related]
22. Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer. Voguet L; Hébert T; Levêque J; Acker O; Mesbah H; Marret H; Porée P; Body G Breast; 2009 Aug; 18(4):233-7. PubMed ID: 19628389 [TBL] [Abstract][Full Text] [Related]
23. Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival. Dieterich M; Hartwig F; Stubert J; Klöcking S; Kundt G; Stengel B; Reimer T; Gerber B Breast; 2014 Aug; 23(4):346-51. PubMed ID: 24559611 [TBL] [Abstract][Full Text] [Related]
24. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Cox CE; Nguyen K; Gray RJ; Salud C; Ku NN; Dupont E; Hutson L; Peltz E; Whitehead G; Reintgen D; Cantor A Am Surg; 2001 Jun; 67(6):513-9; discussion 519-21. PubMed ID: 11409797 [TBL] [Abstract][Full Text] [Related]
25. Breast carcinoma in women 35 years and younger: a pathological study. Fernandopulle SM; Cher-Siangang P; Tan PH Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742 [TBL] [Abstract][Full Text] [Related]
26. A prospective pathologic study to define the clinical target volume for partial breast radiation therapy in women with early breast cancer. Nguyen BT; Deb S; Fox S; Hill P; Collins M; Chua BH Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1116-22. PubMed ID: 22543203 [TBL] [Abstract][Full Text] [Related]
27. Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases. Trentin C; Dominelli V; Maisonneuve P; Menna S; Bazolli B; Luini A; Cassano E Breast; 2012 Oct; 21(5):635-40. PubMed ID: 22795363 [TBL] [Abstract][Full Text] [Related]
28. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit. Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346 [TBL] [Abstract][Full Text] [Related]
29. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases. Han JS; Molberg KH; Sarode V Breast J; 2011; 17(3):223-9. PubMed ID: 21545433 [TBL] [Abstract][Full Text] [Related]
30. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ. Halasz LM; Sreedhara M; Chen YH; Bellon JR; Punglia RS; Wong JS; Harris JR; Brock JE Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e581-6. PubMed ID: 22208975 [TBL] [Abstract][Full Text] [Related]
31. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins. Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190 [TBL] [Abstract][Full Text] [Related]
32. Atypical ductal hyperplasia at margin of breast biopsy--is re-excision indicated? Arora S; Menes TS; Moung C; Nagi C; Bleiweiss I; Jaffer S Ann Surg Oncol; 2008 Mar; 15(3):843-7. PubMed ID: 17987337 [TBL] [Abstract][Full Text] [Related]
33. A two-millimetre free margin from invasive tumour minimises residual disease in breast-conserving surgery. Ward ST; Jones BG; Jewkes AJ Int J Clin Pract; 2010 Nov; 64(12):1675-80. PubMed ID: 20946273 [TBL] [Abstract][Full Text] [Related]
34. Nipple Preservation in Breast Cancer Associated with Nipple Discharge. Chang RY; Cheung PS World J Surg; 2017 Jan; 41(1):176-183. PubMed ID: 27501708 [TBL] [Abstract][Full Text] [Related]
35. Margin index is not a reliable tool for predicting residual disease after breast-conserving surgery for DCIS. Fisher CS; Klimberg VS; Khan S; Gao F; Margenthaler JA Ann Surg Oncol; 2011 Oct; 18(11):3155-9. PubMed ID: 21947593 [TBL] [Abstract][Full Text] [Related]
36. [Evaluation of intraoperative touch imprint cytology of sentinel lymph node for breast cancer]. Huang XY; Wu J; Xu WP; Wang LF; Shi DR; Zhou M; Zhang JX; Han QX; Shen KW; Shen ZZ; Shao ZM Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):596-9. PubMed ID: 18210879 [TBL] [Abstract][Full Text] [Related]
37. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up. Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650 [TBL] [Abstract][Full Text] [Related]
38. Factors affecting successful breast conservation for ductal carcinoma in situ. Dillon MF; Mc Dermott EW; O'Doherty A; Quinn CM; Hill AD; O'Higgins N Ann Surg Oncol; 2007 May; 14(5):1618-28. PubMed ID: 17443388 [TBL] [Abstract][Full Text] [Related]
39. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer. Smitt MC; Horst K Ann Surg Oncol; 2007 Mar; 14(3):1040-4. PubMed ID: 17203329 [TBL] [Abstract][Full Text] [Related]
40. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]